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Mutations in the COPII Vesicle Genes and the Diseases They Lead to 
By Cassandra Concannon 
Abstract 
Protein secretion is essential for cell viability. A large variety of secretory and membrane 
proteins are secreted through the secretory pathway. Studies have revealed how these proteins 
are secreted by analyzing the components of the secretory pathway. The coat protein complex II 
(COPII)-coated vesicles are responsible for generating vesicles at the endoplasmic reticulum. 
During the COPII vesicle assembly the COPII proteins package cargo molecules to nascent 
vesicles. COPII vesicles then fuse with ER/Golgi intermediate compartment in mammalian cells 
or the Golgi apparatus in yeast. The COPII proteins consist of Sar1, Sec23/Sec24 complex, and 
Sec13/Sec31 complex. There are paralogs of most of these proteins in vertebrates which partly 
explain how COPII vesicles package a large variety of proteins. Mutations in one paralog can 
have devastating effects on the individual, while mutations in another paralog may only cause 
mild health issues. By understanding how these COPII proteins function and which proteins they 
interact with, we can learn more about diseases caused by mutations in the genes and possibly 
find ways to cure or better manage these diseases.  
The Secretory Pathway and the Importance of COPII Vesicles 
Eukaryotic cells are composed of many membrane bound organelles and produce a large variety 
of proteins trafficking through the organelles. The trafficking pathway that is responsible for 
releasing the vast majority of proteins to the outside of the cell and to the cell surface is known 
as the secretory pathway. It is estimated that approximately one third of proteins encoded in 
vertebrates’ genome are secreted or transported elsewhere in the cell.  Proteins destined to be 
secreted out of the cell or incorporated to other organelles start at the endoplasmic reticulum 
(ER) where they are produced. Then they are packaged into COPII vesicles and are transported 
to the Golgi apparatus for further modification. These proteins transit through the Golgi cisternae 
and are routed to their destinations. COPII vesicle assembly occurs at an ER exit site, which is a 
special ribosome free area of the ER. (Zahoor et al., 2018) Failure in COPII vesicle formation 
results in accumulation of cargo molecules in the ER and deficit of the proteins to their 
destinations. 
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How COPII Vesicle Formation Works 
COPII vesicle formation is triggered by SAR1, a guanosine triphosphatase (GTPase). SAR1 is 
activated by a guanine exchange factor protein (GEF) called SEC12 which exchanges GDP for 
GTP on SAR1 at the ER exit sites. When SAR1 is bound to GTP it inserts its N-terminal α-helix 
into the ER membrane. This leads to slight tubulation of the membrane and recruitment of the 
heterodimer SEC23/24. Recruited SEC23/24 molecules form the inner coat layer of the vesicle 
coat. Once the SEC23/24 heterodimer is in place, recruitment of the heterotetramer SEC13/31 
occurs, which forms the outer layer of the vesicle coat. SEC23 acts as a GTPase activating 
protein (GAP) for SAR1 and SEC31 stimulates the GAP function of SEC23 further. When SAR1 
hydrolyzes GTP, it leads to dissociation of the COPII coat from the membrane. To help prevent 
early inactivation of Sar1, a membrane bound protein called SEC16 prevents the stimulation of 
SEC23 GAP activity by SEC31. SEC12 also continuously loads new GTPs onto SAR1 
molecules. The assembled vesicle buds off the ER membrane, SEC12 and SEC16 no longer have 
an effect on the coat proteins. SAR1 hydrolyzes the GTP and leads to disassembly of the coat 
proteins as the vesicle travels to the Golgi. (Melero et al., 2018, Vendetti et al., 2014)  
 
It is obvious that these coat proteins have an important job when it comes to secretion of 
proteins. Mutations in these coat proteins have shown a variety of health issues ranging from 
mild health disorders to life altering ones and even lethal disorders. Here I summarize the studies 
on the COPII proteins that lead to better understanding their functions in vertebrates.  
Mutations in SAR1B 
There are two paralogs of SAR1, SAR1A and SAR1B. As of now there are no known diseases 
associated with mutations in the SAR1A gene. 
Mutations in SAR1B causes Anderson’s disease (AD), also known as chylomicron retention 
disease. AD is characterized with symptoms of chronic diarrhea, retarded growth and distended 
abdomen in infants. Endoscopies also show a white frosting on the mucosal surface of the small 
intestine. A study was done on a few children with AD, who at a very young age had the 
symptoms and signs described above. They were all found to have a mutation in the SAR1B 
gene. Biopsies were taken from the small intestine of the AD patients and were compared to 
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healthy individuals. They found that in patients with AD the enterocytes had accumulated a large 
amount of fatty acids and membrane bound lipoprotein sized structures compared to those 
without AD. Blood analysis was also done with blood draws after 12 hours of fasting, then 90 
minutes and 180 minutes after a lipid loaded meal. Fasting lipid levels in AD patients were 
slightly lower than normal compared to healthy subjects, but after eating a lipid loaded meal the 
lipid levels did not significantly change in the AD patients, where the healthy subjects had 
increased triglycerides and chylomicrons. Those with AD can be treated with vitamin 
supplementation and a low-fat diet. Some are able to eat a normal diet and tolerate the amount of 
fats just fine. (Georges et al., 2011)  
A study with Sar1b transgenic mice compared the effects of Sar1b overexpression on mice. They 
found the transgenic mice to have higher bodyweights than wildtype, as well as increased 
glucose and insulin levels causing insulin resistance. The transgenic mice also had hepatic and 
plasma lipid abnormalities and chylomicron hyperproduction, which suggests that intestinal cells 
have increased lipid trafficking with overexpression of Sar1b. (Marcil et al., 2014) 
In another study, a depletion of SAR1B in Caco-2/15 cells resulted in lower amounts of 
apolipoprotein B-48, apolipoprotein A-I and very low-density lipoprotein (VLDL) in the cells. 
The amounts of these lipoproteins were also lower in the media compared to the control cell line. 
The amounts of chylomicrons were also measured and found to have lowered amounts in the 
media of the SAR1B-depleted cells. (Theophile Sane et al., 2017) 
Mutations in SEC23A  
SEC23 is one of two proteins that form the inner coat of COPII vesicles. There are two paralogs 
for this protein, SEC23A and SEC23B. Homozygous mutations in the SEC23A gene cause 
cranio-lenticulo-sutural dysplasia (CLSD). CLSD is characterized by late closing fontanels, 
sutural cataracts, facial dysmorphisms and skeletal defects. Studies show that mutations in 
SEC23A leads to significant decrease in collagen secretion, which could partly explain the 
skeletal features of CLSD. One study analyzed the ER of cells with a heterozygous or 
homozygous mutation of the SEC23A gene. The heterozygous mutant showed a moderate 
dilation of the ER and the homozygous cells showed a severe dilation of the ER due to 
accumulation of cargo molecules compared to the wildtype. (Boyadjiev et al., 2006)  
When Sec23a is mutated in zebrafish, they show similar characteristics as CLSD in humans. 
Mutant fish have truncated body length, various cranial defects, dorsal curvature of the body and 
kinking of the pectoral fins. (Boyadjiev et al., 2006, Lang et al., 2006) Chondrocytes from the 
Sec23a mutant zebrafish showed enlarged ER similar to that shown in cultured cell with Sec23a 
mutations. In zebrafish, knocking out both Sec23a and Sec23b showed similar results to 
knocking out Sec23a alone, but with a moderately smaller cranium. This result suggests that both 
genes play a role in craniofacial cartilage development, and loss of one gene is not compensated 
for by the other paralog. (Lang et al., 2006) 
Mutations in SEC23B 
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Mutations in the SEC23B gene cause congenital dyserythropoietic anemia type II (CDAII). It is 
an autosomal recessive disease and is characterized by mild to moderate anemia due to 
ineffective erythropoiesis, an increase in multinucleated erythroblasts in bone marrow, jaundice 
and splenomegaly. Red blood cells of affected individuals have a double membrane appearance, 
a sign of ineffective erythropoiesis. There have been more than 60 different mutations identified 
in the SEC23B gene that cause CDAII. (Khoriaty et al., 2014). A study was conducted recently 
with mice having mutations in SEC23B, but unfortunately, they were unable to observe 
phenotypes similar to those seen in humans with comparable mutations. Mice born with a 
homozygous Sec23b null mutation died within 24 hours of birth. (Khoriaty et al., 2014).  
Despite not having an animal model mimicking the human phenotypes, there have been multiple 
human studies of CDAII. One study compared SEC23B transcript levels and SEC23B protein 
content from erythroblast cells in CDAII patients and healthy participants. It was found that 
CDAII patients had a 40-60% decrease in mRNA for SEC23B compared to the healthy patients 
and a decrease in protein production in CDAII patients corresponded to the decrease in mRNA. 
(Punzo et al., 2011) No patients were found completely lacking the SEC23B protein which 
suggests that absence of SEC23B gene expression leads to lethality. Since there are a wide 
variety of SEC23B mutations linked to CDAII, a study was done to analyze if a type of SEC23B 
mutations correlates with severity of the disease. 42 people with CDAII participated and their 
hemoglobin levels were checked and their SEC23B genes were sequenced. Patients with addition 
of one missense mutation and one nonsense mutation had the most severe form of anemia and 
patients with two missense mutations had milder conditions. (Iolascon et al., 2010).  
Mutations in SEC24A 
SEC24 forms a heterodimeric complex with SEC23. There are four SEC24 paralogs in 
vertebrates, SEC24A, SEC24B, SEC24C and SEC24D. Deficiency of SEC24A leads to normal 
healthy mice, other than much lower blood cholesterol levels. In the study homozygous or 
heterozygous mice for a Sec24a null mutation were created and compared to wildtype mice. 
Western blots showed absence of SEC24A in the homozygous mutant and significantly less 
protein in the heterozygous mutant than wild type. Amounts of SEC24C and SEC24D were the 
same in all mice but SEC24B was increased significantly in the homozygous mutants and only 
slightly increased in the heterozygous mutants, suggesting that SEC24B was increased to 
compensate for loss of SEC24A. Grossly, there were no differences between wildtype and the 
mutant mice, and they all developed into healthy adults. However, when protein levels in the 
blood plasma were compared, there was a 30-70% decrease in apolipoprotein A-I (APO-A1) in 
the homozygous mutants compared to wildtype. There was also a 40% reduction in total 
cholesterol and high density lipoprotein (HDL) and a 60% decrease in low density lipoprotein 
(LDL) in the blood plasma compared to wildtype. To identify the mechanism underlining this 
observation, they measured levels of proteins known to interact with cholesterol in the blood and 
found that secretion of PCSK9 was reduced by 55%. PCSK9 is a negative regulator of LDL 
receptors (LDLR). The amount of PCSK9 mRNA was the same in mutant and wildtype mice. 
Further analyses of mouse liver cells showed that the amount of PCSK9 was the same between 
mutant and wildtype mice, but in the mutant mice PCSK9 was accumulated in the ER. 
5 
 
Introduction GFP-tagged SEC24A in T cells lead to a reduction of intracellular levels of PCSK9. 
Similar observations were made with SEC24B, albeit to a lesser extent but not with SEC24C and 
SEC24D. (Chen et al., 2013) This shows that SEC24A is necessary for PCSK9 secretion. With a 
reduced secretion of PCSK9, plasma cholesterol levels become lower. However, SEC24A null 
mice are still healthy. It is unclear if SEC24A mutations affect blood cholesterol levels or other 
conditions in humans. 
Mutations in SEC24B 
Studies on neural tube defects have shown a possible link of these defects to SEC24B. One study 
looked at possible causes of a condition called craniorachischisis, which is a lethal defect of 
neural tube closure from hindbrain to the tailbone area resulting is exposure of the spinal cord. A 
forward genetic screen was done looking for recessive mutations that can affect neural 
development in mice. Mouse line 811 was distinguished because homozygous mutants in the line 
developed craniorachischisis. When breeding within this mouse line was done, about 12% of the 
embryos had fully open neural tubes. Sequencing on the embryos with open neural tubes 
identified a causal mutation in Sec24b. The Sec24b mutant embryos were shorter and wider than 
wildtype. They also displayed omphalocele, which is a congenital birth defect where the organs 
develop outside the abdomen, in 45% of the mutant embryos compared to 1% of the control 
embryos. Eyelid fusion was also defective in the mutants with 99% occurrence compared to 2% 
in the control group. Neural tube defects are often associated with aberrations in the planar cell 
polarity (PCP) signaling pathway. It turned out that VANGL2, a protein in the PCP pathway, 
was not found in the plasma membrane in the Sec24b mutant cells. To assess if SEC24B was 
responsible for packaging VANGL2 into COPII vesicles, an invitro budding reaction was done 
where they measured how much VANGL2 was packaged into COPII vesicles with each SEC24 
paralog. There was a significant increase of VANGL2 in the vesicles when SEC24B was present 
but not when other SEC24 paralogs were included, indicating that SEC24B is responsible for 
packaging VANGL2 into vesicles. (Merte et al., 2010). 
A study was done on 163 stillborn and miscarried fetuses with neural tube defects and compared 
them to healthy infants born. Sequencing of the SEC24B gene in the defective fetuses and 
healthy counterparts found four single amino acid substitutions in fetuses and none in any of the 
healthy infants. All four had heterozygous mutations (Phe227Ser, Phe682Leu, Arg1248Gln, 
Ala1251Gly). (Yang et al., 2013) SEC24B may have an effect on neural tube formation defects 
in humans.  
Mutations in SEC24C 
Sec24c knockout mice are embryonic lethal at E7.5. To understand how mutations in SEC24C 
can affect mammals, mouse studies have been done where mice with a floxed Sec24c allele were 
crossed bred with Nes-Cre-transgenic mice. These offspring were then cross bred and gave birth 
to offspring containing homozygous Sec24c conditional knockout (cKO). The homozygous 
Sec24c cKO mutants had microcephaly and died shortly after birth. Their brains weighed 
approximately 50% less than those of wildtype, and staining showed smaller size of cortex in the 
mutants. An immunoblot assay confirmed loss of Sec24c expression in the brains of the mutants, 
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but no change for Sec24a, Sec24b, or Sec24d. There were markedly less neurons in the cortical 
layers of the mutants than controls, which was correlated with an increase of cleaved caspase-3 
in the cortex and thalamus. These results suggest that the microcephaly is caused by apoptotic 
neuronal death. At 16.5 days of gestation, neuron numbers between the mutants and control 
embryos were not altered, suggestion neurogenesis was normal. To evaluate the effect of Sec24c 
mutations postnatally, they were able to delete Sec24c in forebrain excitatory neurons by 
crossing floxed Sec24c mice with Camk2a-Cre-trangenic mice. By 12 months of age, the mutant 
mice showed a significant decrease in brain weight, but not body weight and showed greater 
spontaneous locomotor activity compared to the control mice. Ventricles became larger and 
cortexes became thinner in the mutant mice, than those in control mice. The 2 month old mice 
showed no differences in anatomical structures. They then tested if SEC24D could compensate 
for the loss of SEC24C by creating knock-in mice with Sec24d in place of Sec24c. The 
embryonic lethality at E7.5, which was associated with the germline disruption of Sec24c 
expression, was rescued in the knock-in mice. The brain development between the knock-in mice 
and control at 16.5 days gestation were similar in size and neuron number. The brains of the 
knock-in mice showed no increase in cleaved caspase-3 staining compared with that in littermate 
controls. However, the knock-in mice died shortly after birth, and their body weights were 
noticeably reduced compared to control mice. (Wang et al., 2018) This shows that SEC24C and 
SEC24D are important for controlling apoptosis in neurons and SEC24C and SEC24D have non-
redundant function. There are no human studies as of now.  
Mutations in SEC24D 
Mutations in SEC24D have been shown to decrease collagen secretion, causing osteogenesis 
imperfecta (OI) in humans. Chondrocytes of zebrafish bulldog mutants fail to secrete type 2 
collagen and the mutant embryos have reduced head size, shorter body length, and kinked 
pectoral fins compared to wildtype embryos. The causal mutations were located in the sec24d 
gene. To confirm that sec24d mutations are responsible for the bulldog phenotypes, antisense 
morpholino oligonucleotides (MO) targeting the sec24d 5’UTR were designed. The MO injected 
embryos developed similar characteristics as bulldog mutants. When assessing distribution of 
collagen2α1 at 59 and 62 hours post fertilization (hpf) and 3, 4, and 5 days post fertilization 
(dpf), they found that the collagen primarily localized in the extracellular space and small 
juxtanuclear compartments in the wildtype embryos. In the bulldog mutants, the collagen was 
not detected in the extracellular space and accumulated in chondrocytes. Sec24c is broadly 
expressed throughout the head and jaw region during the first 48 hpf and was present for the 
following two days. When sec24c expression was knocked down using the morpholino strategy 
the resulting embryos were shorter than wildtype but had normal skeletal development of the 
head suggesting sec24c is not involved in cranial development.  
SEC24D mutations can cause OI in humans. This condition is characterized by reduced bone 
mass, increased bone fragility, bone deformity, and growth deficiency. Up to 90% of patients 
with OI have mutations in the COL1A1 and COL1A2 genes which encode for two pro-alpha 
chains on type 1 collagen. Skin fibroblasts taken from a patient having SEC24D mutations 
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showed procollagen accumulation in the ER and dilated ER tubules. (Garbes et al., 2015) Based 
on this data SEC24D appears to be responsible for the export of procollagen from the ER.  
Mutations in SEC13 
Sec13 mutations cause a variety of developmental problems in zebrafish. Sec13sq198 mutant 
zebrafish carries a new splicing acceptor in the sec13 gene. At 2 dpf the mutants and wildtype 
were indistinguishable. At 3 and 4 dpf the expansion of the liver and exocrine pancreas was 
arrested in the mutants. The intestine was also less expanded at the intestinal bulb region in 
mutants. Staining of the embryos at 4 and 5 dpf revealed malformed skeleton cartilage. 
Development of the liver, pancreas, intestine and skeletal cartilage were all impaired in the 
mutants but not differentiation of these tissues. When the amount of phosphorylated histone 3 
(pH3) was measured to see if the cells were arresting the cell cycle it was lowered 2.8 fold in 
intestines of the mutant. In the pancreas it was lowered 4.7 fold in mutants, but there was no 
significant difference in the liver. Apoptotic activity in the liver and intestine of mutant embryos 
was significantly higher than wildtype. Thus, cell cycle arrest and elevated apoptosis lead to the 
hypoplastic digestive organs. Transmission electron microscopy revealed that chondrocytes were 
deformed and disorganized in the mutant embryos. The cytoplasm of the chondrocytes also had 
accumulated dilated vacuole like structures. Antibodies against Col2a showed that Col2a was 
significantly retained in the mutant chondrocytes, while it was secreted in the wildtype 
chondrocytes. (Niu et al., 2012) 
Another zebrafish study suppressed Sec13 and had similar phenotypes as mentioned in the 
previous study, but they also noticed hypomorphic eyes in the zebrafish. Scanning electron 
microscopy at 5dpf revealed the retina was greatly reduced in most of the Sec13 morphants but 
the lens size was similar to wildtype. (Schmidt et al., 2013) 
Mutations in SEC31A 
A recent study showed that mutations in SEC31A can cause a neurological syndrome. Two 
siblings having a homozygous SEC31A mutation presented with intrauterine growth retardation, 
developmental delay, spastic quadriplegia, pseudobulbar palsy, epilepsy, neurosensory deafness 
and optic nerve atrophy. Unfortunately, they both died by the age of 4. Homozygous mapping of 
the siblings, their parents and five other healthy family members was done. It revealed the 
siblings both had a homozygous two-nucleotide insertion mutation in exon 22 of SEC31A that 
caused a truncation of the protein. This mutation also triggers a nonsense mediated decay, 
indicating that this mutation is a null mutation.  
Drosophila sec31a knockout mutants are lethal early on. No larvae or pupae formed with 
homozygous mutations. They also tried knock down studies with the Drosophila but had similar 
early lethality. Knock down of sec31a in the Drosophila eye resulted in severe rough eye 
phenotype with disorganized and fused ommatids. Sec31a knockdown in the Drosophila neurons 
also proved to be lethal early on, but most made it to the larvae stage before they died. 
Neuroblastoma cells where sec31a is deleted by CRISPR/Cas9 failed to expand and generate 
viable clones. (Harperin et al., 2019)  
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Mutations in SEC31B 
In a zebrafish study, sec31a and sec31b morphants showed phenotypes similar to sec13 
morphants with small livers, intestine and pancreas. For eye development sec31b morphants had 
a more profound eye phenotype than sec31a morphants, and the double morphant showed even 
worse eye phenotype in addition to a curved body. Morphants of sec23a, sec23b and sec24c did 
not show defects in retinal lamination. This showed that COPII dysfunction is not the primary 
cause for disruption of retinal lamination. (Niu et al., 2014)  
Gene Human 
Diseases 
Results from Studies 
SAR1A Unknown  
SAR1B Chylomicron 
retention disease 
In humans with mutations, large amounts of fatty acid 
accumulation in enterocytes and lower cholesterol levels. 
Over expression in mice showed elevated lipid levels, and 
chylomicron production 
SEC23A Cranio-lenticulo-
sutural dysplasia 
Zebrafish showed similar characteristics as CLSD patients 
and dilated ERs.  
SEC23B Congenital 
dyserythropoietic 
anemia type II 
In humans, mild to moderate anemia, multinucleated 
erythroblasts in bone marrow, jaundice and splenomegaly. 
Never completely lacking the protein. Mice died within 24 
hours of birth. 
SEC24A Unknown Lower blood cholesterol levels in mice and decreased 
secretion of PCSK9. 
SEC24B Possible neural 
Tube defects 
In mice, neural tube defects present consistent with 
craniorachischisis and decreased VANGL2 secretion. Fetus 
study showed 4 cases of miscarried fetuses with mutations in 
SEC24B and neural tube defects. 
SEC24C Unknown Mouse studies showed microcephaly and decreased number 
of neurons with signs of increased apoptosis of neurons. 
SEC24D Osteogenesis 
imperfecta 
Zebrafish studies showed phenotypes consistent OI. Human 
study showed procollagen accumulation in the ER of skin 
fibroblasts. 
SEC13 Unknown In zebrafish, impaired development of the intestines, liver, 
pancreas, skeletal cartilage and retinas.  
SEC31A Neurological 
syndromes 
Human studies showed neurological syndrome with 
intrauterine growth retardation, developmental delay, spastic 
quadriplegia, pseudobulbar palsy, epilepsy, neurosensory 
deafness and optic nerve atrophy. Both subjects died by age 
of 4. Drosophila studies showed to be lethal early on. 
SEC31B Unknown In zebrafish, impaired development of the intestines, liver, 
pancreas, and skeletal cartilage similar to Sec13 mutants. 
 
Possible Explanation for Different Diseases caused by COPII Mutations 
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Mutations of the COPII genes seem to cause vastly different diseases and conditions despite that 
the COPII proteins all work at the same cellular process. There are many possible explanations 
for why this is the case. For SAR1B it has a weaker affinity to the SEC13/31 heterotetramer than 
SAR1A. This may allow the vesicle to be more flexible for larger cargo like chylomicrons and 
collagen to be loaded into COPII vesicles. Absence of functional SAR1B likely leads to failure 
of packaging larger cargo into COPII vesicles. A similar concept maybe applicable to mutations 
in SEC23A, which leads to decreased collagen export. Perhaps SEC23A has poor recruitment of 
the SEC13/31 heteroteramer, leading to larger vesicles, but if mutated the vesicles remain small. 
(Venditti et al., 2014). COPII paralogs may be responsible for loading specific cargo into the 
COPII vesicles for secretion. For example, the four SEC24 paralogs are classified into two 
groups (SEC24A/SEC24B and SEC24C/SEC24D) based on their amino acid sequence 
homology. Within each group there is 50% identities between the pairs but only 20% identities 
between the two groups. SEC24A is responsible for packaging PCSK9 and SEC24B is 
responsible for packaging VANGL2 into COPII vesicles. (Unlu et al., 2014). Mouse mutants of 
Sec24a or Sec24b showed phenotypes associated with deficiency of PCSK9 and VANGL2, 
respective.  
Tissue specific expression is another possible explanation for why certain diseases occur with 
COPII mutations. SEC23A mutations in humans leads to CLSD and zebrafish have similar 
phenotypes. These were due to decreased collagen secretion and accumulation in the ER of 
fibroblasts. However, in mice SEC23A mutations are lethal in embryos and they developed 
neural tube openings at the midbrain. This indicates that SEC23A may be expressed in different 
tissues across species, causing different phenotypic defects. (Zhu et al., 2015). Differences in the 
expression for each COPII gene may explain why mutations effect certain organ systems or 
tissues.  
Possible Treatment Options 
All of these mutations discussed are rare and are difficult to treat because of the lack of 
knowledge on some of these mutations, and difficultly to do clinical trials on such rare 
conditions. However, some possible treatment options are available. One option is to introduce 
the correct gene into the genome. By using viral vectors, liposomes, microspheres or plasmid 
DNA, a correct gene can be incorporated into the genome so that it produces the correct proteins. 
However, there are still many issues that have to be sorted out before this becomes a realistic 
option. Lifetime is an issue because many of the tissues regenerate cells quickly so it would only 
last for a short period of time, unless the stem cells of tissues are targeted. Transfection efficacy 
is another issue because a low efficiency only has a limited effect on target tissues. Getting the 
DNA into the cell and into the nucleus is difficult, especially if the gene is large. Another issue 
with this approach is safety, especially with viral vectors. There is a chance these altered viruses 
can revert back to their normal functions and become damaging to the body. They also may 
incorporate their own genes into the cell genome, which could lead to other unwanted mutations. 
Lastly, high cost is still an issue with this technique. (Rang et al., 2016) The idea of being able to 
fix mutated genes is appealing, but it has many concerns that need to be addressed.  
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Another treatment option could be the use of CRISPR/Cas9 system. This would work best for 
mutations that are tissue specific such as mutations in SEC23B, which causes congenital 
dyserythropoietic anemia type II. By replacing the mutant gene with the wildtype gene in bone 
marrow stem cells taken from the patient, and then by placing the edited cells back in the patient, 
this approach would allow the cells to produce the correct proteins. Similar trials have been 
completed in mice with success. (Dever et al., 2016). A similar approach could be taken with 
stem cells of the GI tract for patients with SAR1B mutations. The diseases involving multiple 
organ systems and tissues types would be difficult to adopt the CRISPR system to cure the 
diseases. There are still many issues with this gene editing. It is possible that an off-target gene 
can be edited, leading to unwanted mutations. In addition, ethical issues with using the 
CRISPR/Cas9 system have not been resolved in humans.  
Intracellular protein delivery systems would be another option. By using nanocarrier systems 
composed of silica, gold nanoparticles, or polymers, proteins can be delivered intracellularly 
without being degraded. This way those affected by mutations in the COPII coat proteins can 
have functional forms of the proteins for normal protein secretion functions. Many of these 
nanocarriers are relatively non-toxic also and can deliver large proteins. However, this 
technology is still undergoing testing. There are also issues with how effective it is with targeting 
the proteins to the cells. Proteins have different lifespans, so if this becomes a possible treatment 
option, there will need to be ongoing treatment throughout the patient’s life to keep proteins 
levels adequate for function. (Lee et al., 2019).  
Some treatment options have been completed for people with chylomicron retention disease. By 
eating a low fat diet supplemented with lipid soluble vitamins, children resume normal growth 
and the gastrointestinal symptoms improve. There has also been success in controlling symptoms 
in patients taking lipid soluble vitamins and exogenous pancreatic enzyme supplementation 
while eating a normal diet. (Georges et al., 2011) 
Some of the mutations discussed are lethal. To prevent children being born with these mutations, 
parents may seek genetic testing and counseling to evaluate the likelihood of having children 
born with lethal mutations or a disease. However, these mutations are rare, and it is unlikely they 
will be tested for these mutations unless they have specific reasons, such as family history of 
lethal conditions in infancy. Perhaps in vitro fertilization and accompanying selective testing of 
the embryos beforehand for any mutations should be considered for families of high risk.  
Conclusion  
Normal formation of the COPII vesicle coat is important for the health of the individual. Human 
and animal studies have shown solid evidence of what happens when certain COPII coat proteins 
are mutated. We can see that each paralog leads to a vastly different disease, despite working in 
the same cellular process. However, we still have incomplete understanding about these proteins 
and how they affect human health when they become defective. We don’t know if mutations of 
SAR1A, SEC24A, SEC24B, SEC24C, SEC13, and SEC31B cause a disease in humans. It is 
possible that these mutations are lethal in humans so no one is born with it, or it could be that 
these mutations cause such mild symptoms, if any at all, that no disease is detected. For example, 
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according to mouse studies, SEC24A mutations caused lower blood cholesterol, and if this is the 
case there would be no noticeable health issues in humans.  
The other COPII genes are linked to human diseases, but it is still unclear how mutations of the 
COPII genes cause such distinctive diseases. To treat or even cure the COPII diseases we need to 
understand more about physiological functions of COPII proteins and develop disease-specific 
and safer treatment approaches.  
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